The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area)
Citations Over TimeTop 20% of 2015 papers
Abstract
Sickle cell disease is among hereditary diseases with evidence that early diagnoses and treatment improves the clinical outcome. So far sickle cell disease has not been included in the German newborn screening program despite immigration from countries with populations at risk. To determine the birth prevalence we tested 17,018 newborns. High pressure liquid chromatography and subsequent molecular-genetic testing were used for the detection and confirmation of hemoglobin variants. The frequency of sickle cell disease-consistent genotypes was one in 2,385 newborns. Duffy-blood group typing showed evidence that affected children were likely of Sub-Saharan ancestry. An inclusion of sickle cell disease into the German newborn screening seems reasonable.
Related Papers
- → Newborn screening for hemoglobinopathies in California(2008)165 cited
- → Newborn Screening for Sickle Cell Disease Using Tandem Mass Spectrometry(2008)80 cited
- → Newborn Screening for Hemoglobin Disorders(2011)25 cited
- → Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study(2012)6 cited
- Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study Efficacitedu depistage preoperatoire de l'anemie falciforme dans une population al'aide d'un programme de depistage neonatal: une etude de cohorte(2013)